TOP STORIES
Cancer philanthropies – Cancer Fund of America, Cancer Support Services, the Children’s Cancer Fund of America and the Breast Cancer Society – bilked donors out of $187 million, the Federal Trade Commission charged Tuesday. It’s probably a red flag if the office of your charity looks like it’s selling pool tables wholesale from a warehouse.
A worldwide revolt against Sovaldi: activists in several countries are seeking to void payments for the Hepatitis C drug.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
LIFE SCIENCE
Johnson & Johnson is investing $225 million in Achillion to develop and promote its Hepatitis C treatments.
Is ConMed going to start buying to fuel growth?
Johnson & Johnson’s once-a-month anti-psychotic med Invega Sustenna is doing very well, but the company is looking for even bigger sales for its franchise with FDA approval for a longer-acting formula.
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Israel has become the latest country to disclose plans to create a population-scale database of linked genetic and clinical records.
Silk Road Medical won FDA pre-market approval for its Enroute transcarotid stent.
PAYERS-PROVIDERS
Dartmouth-Hitchcock Medical Center, Johns Hopkins and the University of Michigan are setting new guidelines to keep hospitals from performing certain low-volume procedures unless both the hospitals and their surgeons do enough of them often enough to keep their skill level up.
Aetna and the state of Missouri reached at $4.5 million settlement after allegations were filed that the insurer failed to provide coverage for autism treatment.
Insurance companies in Oregon almost universally posted bigger losses than they did last year.
Check out some of the prominent health IT executive moves that occurred within the past eight weeks. And while we’re on the subject, Sutter Health’s CEO Pat Fry is retiring too. The current COO Sarah Krevans will take over early next year, according to Modern Healthcare.
I spoke to a woman last night who said she worries about dating older doctors because she won’t be able to relate to them. For example, she’s still paying school loans. I will send her this article.
ValleyCare Health System and Stanford Health Care have finalized their affiliation agreement.
Updox LLC secured a $3.5 million line of credit to add more features to its physician-patient relations software from SaaS Capital.
TECH
MIT researchers will soon unveil a new algorithm that finds the smallest possible approximation of the original matrix that guarantees reliable computations. More succinctly: it will be able to shrink your big data.
One Medical Group’s members can now use the group’s mobile app to obtain expert evaluation and treatment for common dermatological issues.
Apple is rolling out its first software update for the Apple Watch, which brings Watch OS to version 1.0.1.
Tough terms for Jawbone. Read the details of the terms of its $300 million private equity loan.
POLITICS
John Boehner told a Republican conference meeting Tuesday that he is “proud” the House will be “standing up for the Constitution” when its lawsuit against ObamaCare is heard next week.
Check out this rundown on what the future may hold with the “Cures” bill.
A LITTLE EXTRA
Are you nomophobic? That’s someone who suffers from “no mobile phone” phobia. You might even be reading this on your mobile device right now, in which case I encourage you to check out more stories and stay on the site. But many of us have become just slightly obsessed. Here’s a quiz to help determine out how bad you have it.
The Morning Read provides a 24-hour wrap up of everything else healthcare’s innovators need to know about the business of medicine (and beyond). The author of The Read published it but all full-time MedCity News journalists contribute to its content.
